Rosimer Tablet 80 mg contains Osimertinib, a targeted tyrosine kinase inhibitor (TKI) used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. Osimertinib selectively inhibits epidermal growth factor receptor (EGFR) tyrosine kinases, including both sensitizing and T790M resistance mutations, which are commonly associated with NSCLC progression.

Rosimer is indicated for advanced or metastatic NSCLC patients with EGFR mutations, providing a precise and effective approach to cancer treatment. It is particularly beneficial for patients who have developed resistance to first- or second-generation EGFR inhibitors.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features and Benefits

• Active Ingredient: Osimertinib 80 mg per tablet

• Primary Use: Treatment of EGFR-mutated advanced or metastatic NSCLC

• Mechanism of Action: Selectively inhibits EGFR tyrosine kinases, blocking cancer cell proliferation and survival

• Formulation: Oral tablet for convenient daily administration

• Targeted Therapy: Focused action against EGFR-mutated cancer cells with reduced off-target effects

Benefits

• Provides effective tumor growth control in EGFR-mutated NSCLC

• Offers treatment option for patients with resistance to prior EGFR inhibitors

• Oral administration improves convenience and patient compliance

• Supports precision oncology by targeting cancer cells with minimal impact on healthy tissues

Recommended Dosage

The standard adult dose is 80 mg once daily, taken orally with or without food. Tablets should be swallowed whole and not chewed or crushed.

Treatment should continue until disease progression or unacceptable toxicity occurs, under the supervision of an oncologist. Dose adjustments may be necessary for patients experiencing adverse effects or with impaired liver or kidney function.

Safety Information

While effective, Osimertinib requires careful monitoring:

• Common side effects: Diarrhea, rash, dry skin, fatigue, nausea

• Serious risks: Interstitial lung disease (ILD), QT prolongation, cardiomyopathy, severe infections

• Precautions: Patients with pre-existing heart conditions, liver disease, or lung disease should be closely monitored

Regular medical check-ups, including liver function tests, ECG, and clinical evaluation, are recommended. Any severe or unusual symptoms should be reported immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store Rosimer Tablet 80 mg in a cool, dry place, protected from light and moisture. Keep out of reach of children. Proper storage ensures the stability and efficacy of the medication.

Conclusion

Rosimer Tablet 80 mg by SK Pharma offers a targeted, effective therapy for patients with EGFR-mutated advanced or metastatic NSCLC. Its precision mechanism inhibits cancer cell proliferation, addresses resistance mutations, and provides a convenient oral treatment option, improving patient outcomes under professional oncologist supervision.